Published in Amyotroph Lateral Scler on September 19, 2010
The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum. Ann Med (2012) 1.66
Grey and white matter changes across the amyotrophic lateral sclerosis-frontotemporal dementia continuum. PLoS One (2012) 1.15
Engaging in patient decision-making in multidisciplinary care for amyotrophic lateral sclerosis: the views of health professionals. Patient Prefer Adherence (2012) 1.00
Caregiver burden in amyotrophic lateral sclerosis is more dependent on patients' behavioral changes than physical disability: a comparative study. BMC Neurol (2012) 0.88
Behavior matters--cognitive predictors of survival in amyotrophic lateral sclerosis. PLoS One (2013) 0.87
Caregiver burden in amyotrophic lateral sclerosis: a cross-sectional investigation of predictors. J Neurol (2015) 0.86
ALS and Frontotemporal Dysfunction: A Review. Neurol Res Int (2012) 0.86
Widespread structural and functional connectivity changes in amyotrophic lateral sclerosis: insights from advanced neuroimaging research. Neural Plast (2012) 0.83
Detailed volumetric analysis of the hypothalamus in behavioral variant frontotemporal dementia. J Neurol (2015) 0.83
A Cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: subphenotypes, staging, cognitive predictors, and survival. Ann Clin Transl Neurol (2017) 0.83
Frontal lobe function and behavioral changes in amyotrophic lateral sclerosis: a study from Southwest China. J Neurol (2014) 0.81
Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease. Neurotherapeutics (2015) 0.81
What are the roles of carers in decision-making for amyotrophic lateral sclerosis multidisciplinary care? Patient Prefer Adherence (2013) 0.80
Frontotemporal dementia: diagnosis, deficits and management. Neurodegener Dis Manag (2014) 0.79
Behavioral Symptoms in Motor Neuron Disease and Their Negative Impact on Caregiver Burden. Chin Med J (Engl) (2015) 0.79
Development of a model to guide decision making in amyotrophic lateral sclerosis multidisciplinary care. Health Expect (2013) 0.78
Body mass index delineates ALS from FTD: implications for metabolic health. J Neurol (2014) 0.77
Modeling ALS and FTD with iPSC-derived neurons. Brain Res (2015) 0.77
Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort. Neurology (2016) 0.77
Exploring sarcasm detection in amyotrophic lateral sclerosis using ecologically valid measures. Front Hum Neurosci (2013) 0.77
The frontotemporal syndrome of ALS is associated with poor survival. J Neurol (2016) 0.76
Executive Dysfunctions and Event-Related Brain Potentials in Patients with Amyotrophic Lateral Sclerosis. Front Aging Neurosci (2015) 0.76
Personality disturbances in amyotrophic lateral sclerosis: a case study demonstrating changes in personality without cognitive deficits. J Int Neuropsychol Soc (2014) 0.76
Telephone based cognitive-behavioral screening for frontotemporal changes in patients with amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler Frontotemporal Degener (2016) 0.75
Development of patient decision support tools for motor neuron disease using stakeholder consultation: a study protocol. BMJ Open (2016) 0.75
Microstructural Correlates of Emotional Attribution Impairment in Non-Demented Patients with Amyotrophic Lateral Sclerosis. PLoS One (2016) 0.75
Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival. J Neurol (2016) 0.75
Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach. J Multidiscip Healthc (2017) 0.75
Examining the language and behavioural profile in FTD and ALS-FTD. J Neurol Neurosurg Psychiatry (2017) 0.75
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90
Amyotrophic lateral sclerosis. Lancet (2011) 5.86
The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry (2006) 4.73
Clinical and pathological characterization of progressive aphasia. Ann Neurol (2006) 4.37
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet (2005) 4.21
Structure and deterioration of semantic memory: a neuropsychological and computational investigation. Psychol Rev (2004) 3.32
The pathological basis of semantic dementia. Brain (2005) 2.96
Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes (2006) 2.87
Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol (2013) 2.52
Guillain-Barré syndrome: an update. J Clin Neurosci (2009) 2.46
Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord (2007) 2.43
The syndrome of transient epileptic amnesia. Ann Neurol (2007) 2.37
The effects of very early Alzheimer's disease on the characteristics of writing by a renowned author. Brain (2004) 2.34
Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment. Ann Neurol (2003) 2.26
Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula. Brain (2003) 2.25
Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol (2009) 2.20
Specialization in the medial temporal lobe for processing of objects and scenes. Hippocampus (2005) 2.17
Theory of mind in patients with frontal variant frontotemporal dementia and Alzheimer's disease: theoretical and practical implications. Brain (2002) 2.17
Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol (2011) 2.17
Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol (2011) 2.08
Botulinum toxin modulates cortical maladaptation in post-stroke spasticity. Muscle Nerve (2013) 2.00
Frontotemporal dementia and motor neurone disease: overlapping clinic-pathological disorders. J Clin Neurosci (2009) 1.99
Advances in the early detection of Alzheimer's disease. Nat Med (2004) 1.97
Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain (2008) 1.94
Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using β-amyloid imaging. Brain (2011) 1.92
What the left and right anterior fusiform gyri tell us about semantic memory. Brain (2010) 1.87
Perceptual deficits in amnesia: challenging the medial temporal lobe 'mnemonic' view. Neuropsychologia (2005) 1.83
Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management. Lancet Neurol (2010) 1.79
Language function and dysfunction in corticobasal degeneration. Neurology (2003) 1.78
Left/right asymmetry of atrophy in semantic dementia: behavioral-cognitive implications. Neurology (2003) 1.76
Isolated bulbar phenotype of amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2011) 1.75
Segmental facial anhidrosis and tonic pupils with preserved deep tendon reflexes: a novel autonomic neuropathy. J Neuroophthalmol (2005) 1.63
Diagnostic criteria for corticobasal syndrome: a comparative study. J Neurol Neurosurg Psychiatry (2011) 1.61
Declarative memory impairments in Alzheimer's disease and semantic dementia. Neuroimage (2005) 1.59
Cortical excitability distinguishes ALS from mimic disorders. Clin Neurophysiol (2011) 1.59
Neural correlates of semantic and behavioural deficits in frontotemporal dementia. Neuroimage (2004) 1.58
Naming of objects, faces and buildings in mild cognitive impairment. Cortex (2007) 1.58
Social reasoning, emotion and empathy in frontotemporal dementia. Neuropsychologia (2005) 1.57
Modulatory effects on axonal function after intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy. Arch Neurol (2011) 1.55
Cortical excitability testing distinguishes Kennedy's disease from amyotrophic lateral sclerosis. Clin Neurophysiol (2008) 1.54
Split-hand index for the diagnosis of amyotrophic lateral sclerosis. Clin Neurophysiol (2012) 1.52
Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy. Brain (2009) 1.50
Changes in human sensory axonal excitability induced by an ischaemic insult. Clin Neurophysiol (2008) 1.49
Progressive axonal dysfunction and clinical impairment in amyotrophic lateral sclerosis. Clin Neurophysiol (2012) 1.49
Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease. Brain (2006) 1.47
Corticomotoneuronal function in asymptomatic SOD-1 mutation carriers. Clin Neurophysiol (2010) 1.47
Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging. Arch Neurol (2006) 1.47
Validation of the Addenbrooke's Cognitive Examination III in frontotemporal dementia and Alzheimer's disease. Dement Geriatr Cogn Disord (2013) 1.47
C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts. Neurology (2012) 1.44
FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis. J Neurol Neurosurg Psychiatry (2009) 1.44
Detecting dementia: novel neuropsychological markers of preclinical Alzheimer's disease. Dement Geriatr Cogn Disord (2003) 1.43
Riluzole: a glimmer of hope in the treatment of motor neurone disease. Med J Aust (2005) 1.42
Regional differences in ulnar nerve excitability may predispose to the development of entrapment neuropathy. Clin Neurophysiol (2010) 1.41
Scurvy and stroke - is there an association? Med J Aust (2010) 1.40
Towards evidence-based dementia screening in Australia. Med J Aust (2011) 1.40
Convergent grey and white matter evidence of orbitofrontal cortex changes related to disinhibition in behavioural variant frontotemporal dementia. Brain (2011) 1.39
Clinical significance of lobar atrophy in frontotemporal dementia: application of an MRI visual rating scale. Dement Geriatr Cogn Disord (2007) 1.39
Differentiating the roles of the hippocampus and perirhinal cortex in processes beyond long-term declarative memory: a double dissociation in dementia. J Neurosci (2006) 1.38
The human perirhinal cortex and semantic memory. Eur J Neurosci (2004) 1.38
Oxaliplatin-induced neurotoxicity and the development of neuropathy. Muscle Nerve (2005) 1.37
Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity. J Clin Oncol (2009) 1.37
Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin (2014) 1.36
Neurotoxic marine poisoning. Lancet Neurol (2005) 1.33
Motor neuron dysfunction in frontotemporal dementia. Brain (2011) 1.31
Uremic neuropathy: clinical features and new pathophysiological insights. Muscle Nerve (2007) 1.30
The relationship between affective decision-making and theory of mind in the frontal variant of fronto-temporal dementia. Neuropsychologia (2006) 1.30
Is the pathology of corticobasal syndrome predictable in life? Mov Disord (2009) 1.29
Focal posterior cingulate atrophy in incipient Alzheimer's disease. Neurobiol Aging (2008) 1.28
Axonal ion channels from bench to bedside: a translational neuroscience perspective. Prog Neurobiol (2009) 1.27
Adaptation of the ACE for a Malayalam speaking population in southern India. Int J Geriatr Psychiatry (2004) 1.26
Semantic memory in Alzheimer's disease and the frontotemporal dementias: a longitudinal study of 236 patients. Neuropsychology (2006) 1.25
Face and emotion processing in frontal variant frontotemporal dementia. Neuropsychologia (2002) 1.25
Eating and hypothalamus changes in behavioral-variant frontotemporal dementia. Ann Neurol (2010) 1.24
"Presemantic" cognition in semantic dementia: six deficits in search of an explanation. J Cogn Neurosci (2006) 1.24
Long-term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility. Oncologist (2011) 1.22
Axonal excitability properties in amyotrophic lateral sclerosis. Clin Neurophysiol (2006) 1.22
Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis. Arch Neurol (2010) 1.20
Pathophysiology of neurodegeneration in familial amyotrophic lateral sclerosis. Curr Mol Med (2009) 1.19
Executive function in progressive and nonprogressive behavioral variant frontotemporal dementia. Neurology (2008) 1.19
Mild cognitive impairment: applicability of research criteria in a memory clinic and characterization of cognitive profile. Psychol Med (2006) 1.19
Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis? Amyotroph Lateral Scler (2012) 1.18
Fatigue in multiple sclerosis: mechanisms and management. Clin Neurophysiol (2010) 1.18
Altered nerve excitability properties in established diabetic neuropathy. Brain (2005) 1.17
The Cambridge Semantic Memory Test Battery: detection of semantic deficits in semantic dementia and Alzheimer's disease. Neurocase (2010) 1.17
Atrophy, hypometabolism and white matter abnormalities in semantic dementia tell a coherent story. Brain (2011) 1.17
Factors underlying caregiver stress in frontotemporal dementia and Alzheimer's disease. Dement Geriatr Cogn Disord (2009) 1.17
Semantic knowledge in mild cognitive impairment and mild Alzheimer's disease. Cortex (2006) 1.17
Assessment of cortical excitability using threshold tracking techniques. Muscle Nerve (2006) 1.17
When objects lose their meaning: what happens to their use? Cogn Affect Behav Neurosci (2002) 1.16
Relearning face-name associations in early Alzheimer's disease. Neuropsychology (2002) 1.16
Grey and white matter changes across the amyotrophic lateral sclerosis-frontotemporal dementia continuum. PLoS One (2012) 1.15
Considering the role of semantic memory in episodic future thinking: evidence from semantic dementia. Brain (2012) 1.14
Methylphenidate ('Ritalin') can ameliorate abnormal risk-taking behavior in the frontal variant of frontotemporal dementia. Neuropsychopharmacology (2006) 1.14
Making sense of progressive non-fluent aphasia: an analysis of conversational speech. Brain (2009) 1.14
Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights. J Neurol Neurosurg Psychiatry (2012) 1.14